As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. The founder and managing director (MD) of the country’s largest pharmaceutical firm Sun......
With India’s imports exceeding exports, weak rupee does more harm than good. Analysts, however, say that rupee depriciation is positive for export-oriented sectors such as IT services,......
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent. Stocks took a breather on Friday after two sessions of robust gains as......
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4% Benchmark indices swung between gains and losses on Friday to end the day flat amid lack of global......
Nifty PSU bank index dropped nearly 2% Benchmark indices settled the day lower after trading under pressure throughout the day as investors booked profit ahead of inflation data due today......